Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

AGM Statement

13 Apr 2006 10:15

Flying Brands Limited13 April 2006 13 April 2006 Flying Brands Limited Annual General Meeting Board Change and Trading Statement The Company announces that all the tabled resolutions were passed at its AGM,held in Jersey today. The Board is also pleased to announce that at a meeting held earlier thismorning, Stewart Newton accepted an invitation to join the Board with immediateeffect as a non executive director. Mr Newton is a long term major shareholderin Flying Brands. Commenting on the fourteen weeks of trading to 7 April 2006, Paul Fraser,Chairman, said: "Total sales are 12% ahead of 2005 and are level on a like for like basis.Internet revenue, on a like for like basis, represents 14% of total salescompared to 12% in 2005, up 17% overall. Sales for the Gifts Division are the same as 2005. Valentine's and Mother's Dayssaw record levels of internet sales, with the latter being over 30% of thetotal, up 23% for the campaign. Overall margin has improved 2%. Sales for the Garden Division are 15% above the same period last year, with aparticularly strong performance from Garden Bird Supplies. Gardening Direct'ssales are currently 2% below last year after a flat March mailing, but customerdatabase sales are 6% ahead, hence the margin has improved, and the season stillhas another major campaign later in April. We are continuing the transition ofthe brand towards a direct garden centre positioning, with less reliance onbedding plants. Like for like sales for the Entertainment Division are slightly ahead of thesame period in 2005. Cash generation for the period is £3.7m, 28% ahead of last year. Our strategyremains to extract greater value from our database of 4 million customers and wewill continue to enhance shareholder value by making appropriate acquisitionsand through buying back our own shares for cancellation. We remain confident ofmeeting market expectations for the year." Pursuant to Listing Rule 9.6.13R(1) details of all directorships held by StewartNewton in any publicly-quoted company at any time in the previous five years,are set out below: HSBC Holdings plc For further information, please contact: Flying Brands Limited 01376 575 010 / 07785 346 935Mark Dugdale, Chief ExecutiveGraham Norton, Finance Director Smithfield Consultants 020 7360 4900John KielyGeorge Hudson Notes to editors Stewart Newton Stewart Newton founded Newton Investment Management in 1977. The business wasacquired by Mellon Bank in 1998 and in September 2000 Stewart stepped down asChairman and became non-executive, retiring in March 2002. Since 2003, he hasbeen involved in the Real Return/Veritas Asset Management Group, an investmentgroup focused on real and absolute returns. Stewart is a non-executive directorof HSBC Holdings plc and sits on the investment committee of The Wellcome Trust,and the Investment Board of Cambridge University. Jersey based Flying Brands Limited (LSE: FBDU) is a multi brand home shoppingspecialist. Founded in 1981, it was admitted to the Official List of the LondonStock Exchange in 1993. The Group operates the following divisions: • Gifts (Flying Flowers, the UK's largest flowers by post brand,despatching nearly one million bouquets a year) • Garden (Gardening Direct, one of the UK's largest mail orderbedding plants and gardening products operations; Garden Bird Supplies, aleading provider of food and accessories for birds and other wildlife) • Entertainment (Listen2Books, the leading mail order audio books,DVD and video publisher and distributor; Benham, the first day cover stamps andcoins collectables specialist; Silverminds Direct, the nostalgic music business) More information can be found at: www.flyingbrands.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th May 20257:00 amRNSChange of Name
22nd May 20252:23 pmRNSResult of AGM
2nd May 20257:29 amRNSApplication: FDA Breakthrough Therapy Designation
29th Apr 202510:49 amRNSNotice of AGM
25th Apr 20251:46 pmRNSPublication of Annual Report
11th Apr 20253:32 pmRNSPromising Preliminary Results of Phase 1 Study
18th Mar 202510:38 amRNSPlacing to raise £250,000
3rd Feb 20257:00 amRNSIB Expands Distribution with Blackford
22nd Jan 20257:00 amRNSOperations Update
10th Jan 20257:49 amRNSIB and Prism Secure First Installation
20th Nov 20247:00 amRNSImaging Biometrics Expands Distribution
19th Nov 202411:27 amRNSBoard Changes
5th Nov 20247:00 amRNSNew Patent Application and Trading Update
15th Oct 202410:28 amRNSHolding(s) in Company
14th Oct 202412:08 pmRNSHolding(s) in Company
14th Oct 202412:05 pmRNSPDMR dealing and TR1 announcement
11th Oct 202410:42 amRNSAcquisition of Interest by Braveheart
25th Jun 20249:59 amRNSIB Opens Expanded Access Program
14th Jun 20248:38 amRNSClinical Trial Updates
29th May 20243:08 pmRNSResult of AGM
23rd May 20247:00 amRNSMajor East Coast Health System Chooses IB Nimble
20th May 20247:10 amRNSSecond FDA Rare Pediatric Disease Designation
17th May 20247:00 amRNSIB Software Enhances Clinical Decision-Making
10th May 20248:15 amRNSRare Pediatric Disease Designation Granted to GaM
2nd May 202412:47 pmRNSIB Announces Expanded Access Program for GaM
29th Apr 20243:26 pmRNSPublication of Annual Report
5th Mar 20247:00 amRNSGrant of Options
1st Mar 20248:22 amRNSHolding(s) in Company
1st Mar 20248:20 amRNSHolding(s) in Company
26th Feb 20247:00 amRNSResult of Broker Option and Total Voting Rights
22nd Feb 20247:00 amRNSPlacing and Broker Option
9th Feb 202412:49 pmRNSFDA Application Update
2nd Feb 20248:39 amRNSIB awarded a $100,000 grant
22nd Jan 202410:05 amRNSHolding(s) in Company
15th Jan 20247:01 amRNSDirector Dealings and Conversion of CLNs
15th Jan 20247:00 amRNSHolding(s) in Company
10th Jan 20247:00 amRNSIB Launching an Expanded Access Program for GaM
19th Dec 20232:29 pmRNSImaging Biometrics granted FDA “Fast-Track”
5th Dec 202310:58 amRNSIQ-AI Announces Positive Interim Phase 1 Results
20th Nov 20231:42 pmRNSHolding(s) in Company
9th Nov 202311:38 amRNSDirector Dealing and Conversion of CLNs
8th Nov 202310:59 amRNSApplication for Pediatric Rare Disease Designation
6th Nov 20231:02 pmRNSHolding(s) in Company
18th Oct 20232:29 pmRNSUpdate Regarding Imaging Biometrics LLC
13th Oct 20238:55 amRNSIB Letter to Shareholders
9th Oct 20237:00 amRNSOrphan Drug Status to GaM and Total Voting Rights
3rd Oct 202311:30 amRNSHolding(s) in Company
19th Sep 20232:32 pmRNSIQ-AI shares cease trading on the OTCQB
8th Sep 20237:00 amRNSReduced Gadolinium Approach Validated'
18th Aug 202312:06 pmRNSUpdate on Collaboration Agreement with Mayo Clinic

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.